SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

THE ANGEL–(BUSINESS WIRE) – Schall law firm, a national shareholder rights law firm, has filed a class action lawsuit against Penumbra, Inc. (“Penumbra” or “the Company”) (NYSE: PEN) for violating Sections 10 (b) and 20 (a ) of the Securities Exchange Act of 1934 and Rule 10b-5 published by the US Securities and Exchange Commission.

Investors who purchased the Company’s securities between August 3, 2020 and December 15, 2020 (including the “Class Period”) are advised to contact the Company by March 16, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights at no charge. You can also contact us on the company’s website at www.schallfirm.com or by email at brian@schallfirm.com.

In this case, the class has not yet been certified and you will not be represented by a lawyer until certification. If you don’t take action, you can remain an absent class member.

According to the complaint, the company made false and misleading statements to the market. Penumbra’s Jet 7 Xtra Flex suffered from known design flaws that made the product unsafe. Despite such incidents, the company has not properly addressed the risk of serious injury or death from the use of Jet 7 Xtra Flex. Jet 7 Xtra Flex has likely been recalled for security reasons. Because of these facts, the company’s public statements were false and materially misleading throughout the teaching period. When the market learned the truth about penumbra, investors suffered damage.

Join the case to make up for your losses.

Schall law firm represents investors around the world and specializes in class and shareholder disputes.

This press release may be viewed as a solicitor advertisement in some jurisdictions under applicable laws and ethical rules.

Comments are closed.